D-0026-2026 Class III Ongoing

Recalled by Endo USA, Inc. — Malvern, PA

Recall Details

Product Type
Drugs
Report Date
October 22, 2025
Initiation Date
September 5, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,041 cartons

Product Description

Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 550172301, Exp. Date January 2026